Medically reviewed by Drugs.com. Last updated on Mar 31, 2023.
Applies to the following strengths: 41%; 61%; 76%; 51%; 26%
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Computed Tomography
Computed Tomography: Contrast enhancement of computed tomographic (CECT): cisternography and ventriculography
Neuroradiology: Myelography (lumbar, thoracic, cervical, total columnar)
ISOVUE-M 200 (lopamidol Injection): Thoraco-lumbar myelography
Selective Visceral Arteriography and Aortography
Coronary Arteriography and Ventriculography
Renal Dose Adjustments
Severely renal dysfunction: Caution is recommended, especially in patients with combined renal and hepatic disease, or anuria, particularly when larger doses are administered.
Liver Dose Adjustments
Data not available
US BOXED WARNING:
NOT FOR INTRATHECAL USE: Serious adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use. These serious adverse reactions include: death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. Special attention must be given to ensure that this drug product is not administered intrathecally.
Only the brand ISOVUE-M (lopamidol Injection) is indicated for intrathecal administration.
Consult WARNINGS section for additional precautions.
Data not available
More about iopamidol
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.